Members |
targetComponentId |
akut vesikulärt emfysem |
Pulmonary emphysema |
akut astmatisk bronkit |
Acute bronchitis co-occurrent with wheeze |
akut astmatisk bronkit |
Bronchitis co-occurrent with acute wheeze (disorder) |
Acute yellow atrophy |
Atrophy of liver |
Acute yellow atrophy |
Steatosis of liver |
Acute yellow atrophy |
Acute necrosis of liver |
akut försämring av kroniskt vesikulärt eksem på händer och/eller fötter |
Acute-on-chronic vesicular eczema of feet (disorder) |
akut försämring av kroniskt vesikulärt eksem på händer och/eller fötter |
Acute-on-chronic vesicular eczema of hands (disorder) |
Acute: [bronchitis] or [chest infections] or [tracheobronchitis] |
Acute tracheobronchitis |
Acute: [bronchitis] or [chest infections] or [tracheobronchitis] |
Acute bronchitis (disorder) |
Acute: [bronchitis] or [chest infections] or [tracheobronchitis] |
Acute bronchitis (disorder) |
Acute: [bronchitis] or [chest infections] or [tracheobronchitis] |
Acute tracheobronchitis |
Acute: [lymphadenitis] or [abscess lymph node] or [cervical adenitis] |
Acute cervical adenitis |
Acute: [lymphadenitis] or [abscess lymph node] or [cervical adenitis] |
Acute lymphadenitis |
Acute: [lymphadenitis] or [abscess lymph node] or [cervical adenitis] |
Acute abscess lymph node |
aciklovir 200 mg/5 ml, sockerfri suspension |
Product containing precisely aciclovir 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
adalimumab 40 mg, injektionsvätska, lösning, förfylld spruta 0,8 ml |
Adalimumab 50 mg/mL solution for injection |
Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
Adalimumab 50 mg/mL solution for injection |
adapalen 0,1 %, lotion |
Adapalene 1 mg/mL cutaneous lotion |
adapalen 0,1 %, lösning |
Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Added in error: [FP22] or [GP22] |
Patient deregistration status |
Added in error: [FP22] or [GP22] |
Patient deregistration status |
huggormsgift |
Vipera berus venom (substance) |
huggormsgift |
Puff adder venom |
Addison's disease |
Addison melanoderma |
Addison's disease |
Addison's disease |
ytterligare fynd som rör beteende |
Behavior finding |
Additional swelling / lump observation |
Mass of body structure |
Additional swelling / lump observation |
Swelling |
adduktionstest |
Adduction test of knee |
Adearcoma |
Adenosarcoma |
Adenocarcinoma of colon |
Carcinoma of colon |
Adenocarcinoma of colon |
Primary malignant neoplasm of colon |
implantation i adenoid |
Implantation procedure (procedure) |
implantation i adenoid |
Procedure on adenoids |
Adenosine 3mg/mL injection |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
adenosin 3 mg/ml injektionsvätska, lösning, flaska 2 ml |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Adenosine deaminase superactivity |
Congenital hypoplastic anemia |
Adenosine deaminase superactivity |
Hereditary nonspherocytic hemolytic anemia due to increased adenosine deaminase activity (disorder) |
Adenosine deaminase superactivity |
Constitutional aplastic anemia |
adenotomblad, flergångs |
Surgical blade |
adenotomblad, engångs |
Surgical blade |
Adenovirus (& infection) |
Family Adenoviridae (organism) |
mätning av antikroppar mot adenovirus |
Measurement of adenovirus antibody (procedure) |
Adequate anesthesia |
General anesthesia - under adequate anesthesia (finding) |
Adhesiolysis (& peritoneal) |
Lysis of adhesions |
adherenser i bäckenet hos man |
Adhesion of pelvis (disorder) |
adherenser och rupturer i regnbågshinna och ciliarkropp |
Adhesions of iris |
adherenser och rupturer i regnbågshinna och ciliarkropp |
Disruption of ciliary body (disorder) |
adherenser och rupturer i regnbågshinna och ciliarkropp |
Adhesion of ciliary body (disorder) |
adherenser och rupturer i regnbågshinna och ciliarkropp |
Disruption of iris (disorder) |
Adhesions and disruptions of iris and ciliary body NOS |
Adhesion of ciliary body (disorder) |
Adhesions and disruptions of iris and ciliary body NOS |
Disruption of ciliary body (disorder) |
Adhesions and disruptions of iris and ciliary body NOS |
Adhesions of iris |
Adhesions and disruptions of iris and ciliary body NOS |
Disruption of iris (disorder) |
tjock självhäftande filt, 22,5 cm x 10 cm x 5 mm |
Adhesive felt |
Adhesive capsulitis of shoulder |
Adhesive capsulitis of shoulder (disorder) |
Adhesive capsulitis of shoulder |
Scapulohumeral fibrositis |
självhäftande filt, 10,5 cm x 8,3 cm x 5 mm |
Adhesive felt |
Adhesive sealing |
Closure - action |
vidhäftningsmedel, bandage och/eller sutur |
Adhesive plaster |
vidhäftningsmedel, bandage och/eller sutur |
Bandage |
vidhäftningsmedel, bandage och/eller sutur |
Suture (physical object) |
apidös hornhinnedystrofi |
Reis-Bucklers' corneal dystrophy |
apidös hornhinnedystrofi |
Fatty degeneration of cornea |
Adiposity |
Simple obesity (disorder) |
Adiposity |
Simple obesity (disorder) |
Adiposity |
Simple obesity (disorder) |
Adiposity |
Obesity (disorder) |
Adiposity |
Obesity (disorder) |
Adiposity |
Obesity (disorder) |
adjuvant behandling vid hypertyreos |
Adjunctive drug therapy for treatment of thyrotoxicosis (procedure) |
justering av maxillofacial protes eller tillbehör |
Adjust mandibular resection prosthesis |
justering av maxillofacial protes eller tillbehör |
Adjust extraoral maxillofacial prosthesis |
Adjustment |
Adjustment (procedure) |
Adjustment |
Adjustment (attribute) |
Adjustment reaction NOS |
Adjustment disorder |
Adjustment to: [skeletal traction] or [Kirschner wire] |
Adjustment to Kirschner wire (procedure) |
Adjustment to: [skeletal traction] or [Kirschner wire] |
Adjustment to skeletal traction of bone |
Adjuvant |
Incomplete adjuvant |
Adjuvant |
Freund's adjuvant |
Adjuvant |
Immunologic adjuvant (substance) |
adjuvant behandling vid brucellos |
Adjunctive drug therapy for treatment of brucellos |
adjuvant behandling vid tuberkulös meningit |
Adjunctive drug therapy for treatment of tuberculosis of meninges (procedure) |
Administration of botulism antitoxin |
Injection of botulism antitoxin (procedure) |
Administration of botulism antitoxin |
Administration of botulism antitoxin (procedure) |
Administration of botulism antitoxin |
Infusion of botulism antitoxin (procedure) |
Administration of cancer treatment |
Administration of antineoplastic agent |
Administration of cancer treatment |
Administration of antineoplastic agent |
Administration of cancer treatment |
Administration of antineoplastic agent |
Administration of eye drugs -[no drugs here] |
Instillation of eye drops to eye (procedure) |
Administration of eye drugs -[no drugs here] |
Applying medication to eyes |
administrering av vaccin mot humant papillomvirus, typ 4 |
Administration of vaccine product containing only Human papillomavirus 6, 11, 16 and 18 antigens (procedure) |
oral administrering av levande tyfoidvaccin |
Administration of live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product via oral route |
administrering av heptavalent konjugerat vaccin mot pneumokocker |
Administration of pneumococcal 7-valent conjugate vaccine |
administrering av 23-valent pneumokockpolysackaridvaccin |
Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) |
Administration of saline solution |
Infusion of saline solution |
Administration of saline solution |
Intra-arterial infusion of saline |
Administration of steroid |
Infusion of steroid |
Administration of steroid |
Injection of steroid |
Administration of steroid |
Administration of steroid |